Viknesh Selvarajah

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Estimation of skin sodium content via 23Na magnetic resonance imaging at 3 T using a single-loop surface transmit/receive coil.

Estimation of skin sodium content via 23Na magnetic resonance imaging at 3 T using a single-loop surface transmit/receive coil.

Journal: Magma (New York, N.Y.)

Published: February 02, 2026

International Environmental Impact of CKD Care.

International Environmental Impact of CKD Care.

Journal: Kidney international reports

Published: October 09, 2025

Inhibition of IL-33 in Diabetic Kidney Disease: A Randomized, Placebo-Controlled Phase 2b Trial.

Inhibition of IL-33 in Diabetic Kidney Disease: A Randomized, Placebo-Controlled Phase 2b Trial.

Journal: Journal of the American Society of Nephrology : JASN

Published: July 09, 2025

Pharmacokinetic-pharmacodynamic (PK/PD) modelling of cotadutide effect in patients with chronic kidney disease and type 2 diabetes mellitus.

Pharmacokinetic-pharmacodynamic (PK/PD) modelling of cotadutide effect in patients with chronic kidney disease and type 2 diabetes mellitus.

Journal: British journal of clinical pharmacology

Published: November 13, 2024

Using Chronic Kidney Disease as a Model Framework to Estimate Healthcare-Related Environmental Impact.

Using Chronic Kidney Disease as a Model Framework to Estimate Healthcare-Related Environmental Impact.

Journal: Advances in therapy

Published: August 14, 2024

Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group.

Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: June 03, 2024

A randomized phase 2b trial examined the effects of the glucagon-like peptide-1 and glucagon receptor agonist cotadutide on kidney outcomes in patients with diabetic kidney disease.

A randomized phase 2b trial examined the effects of the glucagon-like peptide-1 and glucagon receptor agonist cotadutide on kidney outcomes in patients with diabetic kidney disease.

Journal: Kidney international

Published: April 19, 2024

Renal Autotransplantation for Uncontrolled Hypertension in Nonatherosclerotic Renal Artery Stenosis-2 Case Reports and a Brief Review of the Literature.

Renal Autotransplantation for Uncontrolled Hypertension in Nonatherosclerotic Renal Artery Stenosis-2 Case Reports and a Brief Review of the Literature.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: March 20, 2024

Inhibition of Interleukin-33 to Reduce Glomerular Endothelial Inflammation in Diabetic Kidney Disease.

Inhibition of Interleukin-33 to Reduce Glomerular Endothelial Inflammation in Diabetic Kidney Disease.

Journal: Kidney international reports

Published: February 07, 2024

Prediction of cardiovascular risk factors from retinal fundus photographs: Validation of a deep learning algorithm in a prospective non-interventional study in Kenya.

Prediction of cardiovascular risk factors from retinal fundus photographs: Validation of a deep learning algorithm in a prospective non-interventional study in Kenya.

Journal: Diabetes, obesity & metabolism

Published: December 22, 2023

Clinical impact of tissue sodium storage.

Clinical impact of tissue sodium storage.

Journal: Pediatric nephrology (Berlin, Germany)

Published: February 24, 2019

Skin Sodium and Hypertension: a Paradigm Shift?

Skin Sodium and Hypertension: a Paradigm Shift?

Journal: Current hypertension reports

Published: September 15, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026